Skip to main content
logo
Repare Therapeutics Inc. (RPTX)
2.650
+0.020 (0.76%)
Inactive · Last trade price on Jan 27, 2026

Repare Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
114563086178801,261
Market Cap Growth
94.73%-81.89%-50.18%-29.87%-30.20%-
Enterprise Value
2-12161253619917
Last Close Price
2.651.317.3014.7121.0934.30

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
9.541.046.024.68115.829341.04
PB Ratio
0.990.371.452.213.054.40
P/TBV Ratio
0.990.371.452.213.054.40
P/OCF Ratio
---1916.94--

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
0.13-1.201.9281.466794.23

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.000.010.020.020.030.01
Asset Turnover
0.070.250.170.360.020.00
Quick Ratio
10.406.536.114.439.8430.86
Current Ratio
10.716.776.244.5010.0231.47
Return on Equity (ROE)
-49.78%-46.63%-38.16%-10.23%-37.17%-28.36%
Return on Assets (ROA)
-29.72%-26.76%-23.51%-3.38%-18.71%-14.76%
Return on Capital Employed (ROCE)
-68.80%-60.90%-54.10%-6.90%-32.60%-15.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-63.43%-152.08%-30.50%-4.71%-12.15%-4.24%
FCF Yield
-61.63%-137.27%-41.98%-0.04%-9.94%-0.66%
Buyback Yield / Dilution
-1.02%-0.76%-0.41%-10.85%-88.66%-1211.56%
SEC Filings: 10-K · 10-Q